The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a meta-analysis

被引：0
|
作者：
Floyd, C. N. [1 ]
Ferro, A. [1 ]
机构：
[1] Kings Coll London, London, England
来源：
JOURNAL OF HUMAN HYPERTENSION | 2013年 / 27卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：641 / 641
页数：1
相关论文
共 50 条
  • [31] No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction
    Lagercrantz, J
    Bergman, M
    Lundman, P
    Tornvall, P
    Hjemdahl, P
    Hamsten, A
    Eriksson, P
    BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (08) : 749 - 753
  • [32] Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein Illa polymorphism in patients with coronary artery disease
    Dropinski, Jerzy
    Musial, Jacek
    Sanak, Marek
    Wegrzyn, Wojciech
    Nizankowski, Rafal
    Szczeklik, Andrew
    THROMBOSIS RESEARCH, 2007, 119 (03) : 301 - 303
  • [33] A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease
    Burr, D
    Doss, H
    Cooke, GE
    Goldschmidt-Clermont, PJ
    STATISTICS IN MEDICINE, 2003, 22 (10) : 1741 - 1760
  • [34] Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis
    Wang, Jing
    Liu, Jie
    Zhou, Yaqing
    Wang, Fei
    Xu, Ke
    Kong, Deyu
    Bai, Jianling
    Chen, Jun
    Gong, Xiaoxuan
    Meng, Haoyu
    Li, Chunjian
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] Association among PlA1/A2 gene polymorphism, laboratory aspirin resistance and clinical outcomes in patients with coronary artery disease: An updated meta-analysis
    Jing Wang
    Jie Liu
    Yaqing Zhou
    Fei Wang
    Ke Xu
    Deyu Kong
    Jianling Bai
    Jun Chen
    Xiaoxuan Gong
    Haoyu Meng
    Chunjian Li
    Scientific Reports, 9
  • [36] The platelet PlA1/A2 (glycoprotein IIIa) and HPA2 (glycoprotein Ib alpha) polymorphisms and the relationship between carotid artery intima-media thickness and platelet activation
    Lukasik, M
    Rozalski, M
    Boncler, M
    Watala, C
    Kozubski, W
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E84 - E85
  • [37] Glycoprotein IIIa P1A1/A2 polymorphism and sudden cardiac death
    Mikkelsson, J
    Perola, M
    Laippala, P
    Penttilä, A
    Karhunen, PJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) : 1317 - 1323
  • [38] Platelet antigen 1/platelet antigen 2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis
    Floyd, Christopher N.
    Mustafa, Agnesa
    Ferro, Albert
    LANCET, 2014, 383 : 49 - 49
  • [39] Pla1/A2 polymorphism, aspirin and the tissue factor-initiated coagulation at sites of microvascular injury
    Undas, A
    Brummel, K
    Musiai, J
    Mann, KG
    Szczeklik, A
    CIRCULATION, 2000, 102 (18) : 333 - 334
  • [40] PlA1/PlA2 polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty
    Verdoia, Monica
    Pergolini, Patrizia
    Camaro, Cyril
    Restifo, Maria
    Rolla, Roberta
    Schaffer, Alon
    Di Giovine, Gabriella
    Marino, Paolo
    Bellomo, Giorgio
    Suryapranata, Harry
    De Luca, Giuseppe
    BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (04) : 411 - 418
12345